XML 115 R76.htm IDEA: XBRL DOCUMENT v3.22.1
Equity - Summary of the Warrants (Details) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Stockholders Equity Details [Line Items]    
Number of shares 29,404,809 42,686,195
Dragasac Warrant    
Stockholders Equity Details [Line Items]    
Number of shares 6,529,818 6,529,818
Exercise price $ 6.77 [1] $ 6.77 [2]
Expiration date Mar. 16, 2025 Mar. 16, 2025
March 2020 Series B Warrants    
Stockholders Equity Details [Line Items]    
Number of shares   13,281,386
Exercise price   $ 7.53
Expiration date   Mar. 16, 2025
Public Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 14,374,992 14,374,992
Exercise price $ 11.5 $ 11.5
Expiration date Jul. 16, 2026 Jul. 16, 2026
Sponsor Warrants    
Stockholders Equity Details [Line Items]    
Number of shares 8,499,999 8,499,999
Exercise price $ 11.5 $ 11.5
Expiration date Jul. 16, 2026 Jul. 16, 2026
[1] The exercise price is the lessor of $6.77 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.
[2] The exercise price is the lesser of $6.77 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.